Highlights: New genetic study links GLP-1 receptor activation to better mental well-being Researchers found lower genetic odds of depression and bipolar disorder Experts say the findings are promising but not yet ready for clinical use medications targeting the glucagon-like peptide-1 (GLP-1) receptor, better known as GLP-1 drugs, may do more than help people lose weight or control diabetes
Schneider, D
Many cases are reversible and manageable with simple steps rather than permanent problems
Joseph Pizzorno, ND, and Editor in Chief of Integrative Medicine: A Clinicians Journal, said it best: Clearly, adequate availability of Glutathione is critical for maintaining health, protecting the body from toxins, and promoting longevity. References:
NAD+ Drip Support cellular repair and boost your metabolism with our NAD+ Drip
This blend pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GHS-R1a agonist